Monday, November 23, 2009

Heart Disease Home>
News>
FDA gives Micardis wider approval

Font size
- A
- A
- A
Email This

Bookmark

Save

FDA gives Micardis wider approval

(HealthScout) UPDATED 2009-10-19

The U.S. Food and Drug Administration (FDA) has approved the heart drug Micardis for people ages 55 and older who are at high risk for heart attacks and stroke, but who cannot take ACE inhibitors. The FDA also approved a new drug that is a combination of Micardis and the calcium channel blocker Norvasc. This combination drug--called Twnysta--is designed to prevent high blood pressure when used alone or as an add-on treatment with another blood pressure med. Read full story >

See all Heart Disease News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyHeartCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.